Polar Asset Management Partners’s Revelation Biosciences Warrant REVBW Stock Holding History

Polar Asset Management Partners’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-98,296	Closed	-$1.35K	–	1135
2022 Q4	$1.35K	Hold	98,296	–	–	﹤0.01%	1209
2022 Q3	$5K	Hold	98,296	–	–	﹤0.01%	1316
2022 Q2	$8K	Hold	98,296	–	–	﹤0.01%	1288
2022 Q1	$12K	Hold	98,296	–	–	﹤0.01%	1167
2021 Q4	$67K	Sell	98,296 -449,214	-82%	-$275K	﹤0.01%	1179
2021 Q3	$340K	Hold	547,510	–	–	﹤0.01%	906
2021 Q2	$350K	Sell	547,510 -152,490	-22%	-$90.9K	﹤0.01%	846
2021 Q1	$364K	Buy	700,000 +350,000	+100%	+$327K	﹤0.01%	646
2020 Q4	$312K	Buy	+350,000	New	+$239K	﹤0.01%	666

Other funds holding REVBW

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Polar Asset Management Partners's REVBW Position: Q1 2023 in Review

Polar Asset Management Partners sold out of Revelation Biosciences Warrant (REVBW) in Q1 2023, closing a stake of 98,296 shares — an estimated $1.35K sold.

Polar Asset Management Partners first reported a position in REVBW in Q4 2020 and held it in 9 quarters. The position peaked at $364K in Q1 2021. 17 funds tracked by Wall St. Rank hold REVBW as of Q1 2023.

Polar Asset Management Partners reported no remaining Revelation Biosciences Warrant position as of Q1 2023 after selling out during the quarter.
Polar Asset Management Partners sold 98,296 Revelation Biosciences Warrant shares in Q1 2023, an estimated $1.35K.
Polar Asset Management Partners first reported a position in Revelation Biosciences Warrant in Q4 2020 and held it in 9 quarters.
Polar Asset Management Partners's Revelation Biosciences Warrant position peaked at $364K in Q1 2021.
17 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q1 2023.

Based on Polar Asset Management Partners's 13F filing for Q1 2023, filed 15 May 2023.